Independent role of atherosclerotic plaque composition and extension in predicting the risk of cardiac events: a CLIMA substudy
Authors:
- 21 October 2024
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 40 (12) , 2535-2543
Abstract
To investigate two different approaches to determine patient risk to develop cardiac events: the burden of coronary atherosclerosis, as assessed by the Gensini score, and plaque morphology, as assessed by intracoronary optical coherence tomography (OCT). We assessed the Gensini score and OCT features of plaque vulnerability in 847 patients from the CLIMA registry. Patients were divided into four Gensini quartiles. The main study endpoint was the 1-year composite of cardiac death, myocardial infarction (MI) and/or target vessel revascularization (TVR). A total of 56 patients (6.6%) experienced the one-year main composite endpoint. The composite endpoint was significantly affected by the Gensini score (hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.11–1.81, p = 0.005), with a low incidence in the first Gensini quartile (Q1 1.3%) and a higher incidence in the remaining groups (Q2 8.3%, Q3 8.9% and Q4 8.3%). At the multivariable analysis, the combined four OCT criteria (HR 6.4, 95%CI 3.0-13.7, p < 0.001), thin fibrous cap (HR 2.9, 95%CI 1.7-5.0, p < 0.001), lipid arc > 180° (HR 2.1, 95%CI 1.2–3.6, p = 0.010), minimum lumen area < 3.5 mm2 (HR 1.7, 95%CI 1.01-3.0, p = 0.047) and the Gensini score (HR 1.4, 95%CI 1.1–1.8, p = 0.017) were independent predictors of the main composite endpoint. In this post-hoc analysis of the CLIMA study, the burden of coronary atherosclerosis as assessed by the Gensini score and OCT plaque characteristics were independent predictors of cardiac events. Patients with the largest atherosclerosis burden and with plaque vulnerability by OCT were at the highest risk of poor outcome. Clinicaltrials.gov identifier: NCT02883088. Graphical AbstractKeywords
This publication has 27 references indexed in Scilit:
- Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trialThe Lancet, 2024
- Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering TherapyJACC, 2023
- Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial InfarctionJACC: Cardiovascular Imaging, 2022
- Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery DiseaseJACC, 2019
- Coronary Atherosclerotic Precursors of Acute Coronary SyndromesJACC, 2018
- Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-UpJACC, 2015
- High-Risk Plaque Detected on Coronary CT Angiography Predicts Acute Coronary Syndromes Independent of Significant Stenosis in Acute Chest PainJACC, 2014
- Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography StudiesJACC, 2012
- From plaque biology to clinical settingAmerican Heart Journal, 1999
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983